Combination Approach Could Overcome Treatment Resistance in Deadly Breast Cancer
4 Articles
4 Articles


Combination approach could overcome treatment resistance in deadly breast cancer
QIMR Berghofer-led research in collaboration with Australian oncology company Kazia Therapeutics has found that combining the drug candidate paxalisib with immunotherapy triggered a molecular epigenetic process that prevented the spread of cancer cells and overcame treatment resistance in preclinical models of triple negative breast cancer.
'Ring the bell' end of treatment party raises £2,440 for Breast Care Unit | West Wales Chronicle : News for Llanelli, Carmarthenshire, Pembrokeshire, Ceredigion, Swansea and Beyond
Jolene Saunders held a ‘ring the bell’ end of treatment party and raised £2,440 for the Breast Care Unit at Prince Philip Hospital. Jolene is a 37-year-old farmer from Alltwalis who lives with her husband, Aled, and two sons, Elis and Gwion. Jolene held the party in Neath Rugby Club in April to raise the funds as a thanks for the care she received on the unit. Jolene said: “In June 2024, I was diagnosed with Stage 2 Invasive Ductal Carcinoma. I …
Combination approach could overcome treatment resistance in deadly bre
There is an urgent need to develop new treatments for patients with metastatic breast cancer, which is highly aggressive and difficult to treat. QIMR Berghofer-led research in collaboration with Australian oncology company, Kazia Therapeutics, has found that combining the drug candidate paxalisib with immunotherapy triggered a molecular epigenetic process that prevented the spread of cancer cells and overcame treatment resistance in preclinical …
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium